These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33303370)

  • 1. Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
    Murata T; Watase C; Shiino S; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    Clin Breast Cancer; 2021 Aug; 21(4):e302-e311. PubMed ID: 33303370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
    Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
    Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
    Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
    Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
    Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a nomogram prediction model for axillary lymph node metastasis of cT1 invasive breast cancer.
    Wang S; Wang D; Wen X; Xu X; Liu D; Tian J
    Eur J Cancer Prev; 2024 Jul; 33(4):309-320. PubMed ID: 37997911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
    van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
    Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
    Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
    J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer.
    Abe H; Schacht D; Sennett CA; Newstead GM; Schmidt RA
    AJR Am J Roentgenol; 2013 Mar; 200(3):696-702. PubMed ID: 23436865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.
    Yu Y; Wang Z; Wei Z; Yu B; Shen P; Yan Y; You W
    BMC Cancer; 2021 Apr; 21(1):466. PubMed ID: 33902502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?
    Neal CH; Daly CP; Nees AV; Helvie MA
    Radiology; 2010 Nov; 257(2):335-41. PubMed ID: 20807849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasound.
    Meretoja TJ; Heikkilä PS; Mansfield AS; Cserni G; Ambrozay E; Boross G; Zgajnar J; Perhavec A; Gazic B; Arisio R; Tvedskov TF; Jensen MB; Leidenius MH
    Ann Surg Oncol; 2014 Jul; 21(7):2229-36. PubMed ID: 24664623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study.
    Noda S; Onoda N; Asano Y; Kurata K; Tokumoto M; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
    Int J Surg; 2016 Feb; 26():1-5. PubMed ID: 26700202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
    Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
    Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
    Orozco JIJ; Le J; Ensenyat-Mendez M; Baker JL; Weidhaas J; Klomhaus A; Marzese DM; DiNome ML
    Ann Surg Oncol; 2022 Oct; 29(10):6407-6414. PubMed ID: 35842534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.